Bernstein initiated coverage of BioNTech (BNTX) with a Market Perform rating and $96 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNTX:
- BioNTech Shareholders Back All Proposals and Strengthen Supervisory Board at 2026 AGM
- Davis to become acting director of CDER after Hoeg exit, Bloomberg says
- Trump confirms Kyle Diamantas to be acting head of FDA
- Trump Trade: Trump to suspend tariff-rate quotas on beef imports
- Berenberg cuts BioNTech target, says shares ‘deeply’ undervalued